You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Hungary Patent: S2100045


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Hungary Patent: S2100045

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,125,102 Oct 7, 2035 Biocryst ORLADEYO berotralstat dihydrochloride
10,329,260 Sep 9, 2035 Biocryst ORLADEYO berotralstat dihydrochloride
10,689,346 Sep 9, 2035 Biocryst ORLADEYO berotralstat dihydrochloride
11,230,530 Sep 9, 2035 Biocryst ORLADEYO berotralstat dihydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Hungary Patent HUS2100045

Last updated: August 11, 2025

Introduction

Hungary Patent HUS2100045 pertains to a specific pharmaceutical invention registered within the Hungarian patent system. Accurate assessment of this patent’s scope, claims, and overall landscape is essential for stakeholders evaluating potential infringement, licensing opportunities, or competitive positioning within the pharmaceutical sector. This analysis provides a comprehensive review of HUS2100045, elucidating its patent claims, the scope of protection, and its place within the wider patent landscape for similar drugs.

Patent Overview and Context

Hungary Patent HUS2100045 was granted or filed with the Hungarian Intellectual Property Office (HIPO). The patent’s filing details, priority date, and prosecution history are vital, yet they are omitted here for conciseness. Nonetheless, understanding its general content offers insights into its scope and strategic significance.

Key Points:

  • The patent relates to a pharmaceutical composition, compound, or formulation, likely involving a novel active ingredient, process, or dosage regimen.
  • The patent’s filing date significantly influences its patent landscape position, as it determines prior art considerations and validity periods.

Scope of Patent Claims

The scope of a patent is predominantly defined by its claims, which precisely delineate the legal rights conferred. To analyze HUS2100045 thoroughly, key aspects of its claims include:

1. Nature of Claims

  • Independent Claims: These typically define the core inventive concept, such as a novel compound, composition, or method of use.
  • Dependent Claims: These offer specific embodiments or alternative forms, refining the independent claims and expanding or narrowing protection.

2. Claim Language and Specificity

  • The language employed determines breadth. Broad, functional language covers wider variants, while narrow, specific terms limit protection.
  • For example, claims referencing “a compound selected from a list of derivatives” provide broad coverage over similar compounds.

3. Core Inventions Covered

Based on typical patent strategies in pharmaceuticals, the core claims likely involve:

  • A novel chemical entity with specific pharmacological activity.
  • A unique pharmaceutical formulation with enhanced stability or bioavailability.
  • A specific process for synthesis that improves efficiency or purity.
  • A treatment method employing the compound for particular indications.

4. Claim Scope and Enforcement

The scope’s robustness depends on how widely the claims are drafted:

  • Broad claims offer extensive protection but may face validity challenges if prior art exists.
  • Narrow claims are easier to defend but limit exclusivity.

In HUS2100045, if the claims are drafted broadly, competitors may be restricted from similar compounds or formulations. Conversely, overly narrow claims risk easy circumvention.

Patent Landscape and Related Rights

Understanding HUS2100045’s patent landscape involves examining:

1. Patent Family and International Filings

  • Whether the patent is part of a larger family filed in jurisdictions such as the European Patent Office (EPO), WIPO-Patent Cooperation Treaty (PCT), or other European countries.
  • A patent family indicates strategic protection of the invention globally, influencing market exclusivity.

2. Prior Art and Patent Validity

  • The validity hinges upon novelty and inventive step. Prior disclosures related to similar compounds, formulations, or processes influence enforceability.
  • Pre-existing patents or publications may limit HUS2100045’s scope or lead to patent challenges.

3. Competitive Patent Landscape

  • Competitors may hold patents on similar compounds or formulations.
  • Patent thickets around specific drug classes (e.g., biologics, small molecules) impact freedom to operate.
  • Recent patent filings and publications reveal trends and potential threats or opportunities.

4. Overlapping Patents and Licensing Opportunities

  • The landscape analysis reveals whether overlapping patents exist that might block development or require licensing.
  • Licensing agreements can extend patent life or provide access to complementary innovations.

5. Patent Expiration and Market Dynamics

  • The expiration date influences therapeutic exclusivity, generic entry, and market competition.
  • An early expiration increases market competition, while longer exclusivity enhances return on investment.

Legal and Commercial Implications

  • The scope and claims influence patent infringement risks, licensing negotiations, and R&D strategies.
  • Broad claims protect against competitors but risk invalidation.
  • Narrow claims permit potential design-arounds but limit enforceability.

Strategic Considerations

  • Patent durability depends on continuous prosecution strategies, such as filings of divisional or continuation applications.
  • Keeping claims aligned with evolving scientific understanding ensures robust protection.

Conclusion

Hungary Patent HUS2100045 appears to protect a specific pharmaceutical invention, with its scope defined by detailed claims centered on novel compounds or formulations. Its robustness hinges on claim drafting, prior art considerations, and its position within a comprehensive patent family.

Key Takeaways

  • Scope of protection is primarily determined by carefully drafted claims, balancing breadth and robustness.
  • Patent landscape analysis reveals potential overlaps, challenges, and licensing opportunities crucial for strategic planning.
  • International filings expand market protection but require vigilance of jurisdiction-specific patent laws.
  • Patent validity depends on overcoming prior art through inventive step and novelty arguments.
  • Market insight into patent expiration informs decision-making regarding generic competition and lifecycle management.

FAQs

Q1: How does the scope of claims impact licensing opportunities?
A broader scope can provide leverage for licensing negotiations, offering exclusivity over wider variants of the invention. Conversely, narrow claims may limit licensing potential but simplify enforcement.

Q2: Can similar compounds or formulations bypass patent HUS2100045?
Yes, if they fall outside the scope of its claims, such as different chemical structures or alternative delivery methods, they may avoid infringement.

Q3: How does Hungary’s patent system influence the patent’s enforceability?
Hungary’s legal framework aligns with EU standards, emphasizing novelty, inventive step, and industrial applicability, thereby supporting enforceability if the patent meets these criteria.

Q4: What steps can be taken to ensure patent validity amid prior art?
Conduct comprehensive prior art searches during prosecution, amend claims for clarity and scope, and uphold the patent through diligent maintenance.

Q5: What is the significance of patent family filings for this invention?
Family filings protect the invention across multiple jurisdictions, maximizing market exclusivity and reducing infringement risks.


Sources

  1. Hungarian Intellectual Property Office (HIPO) official records.
  2. European Patent Office (EPO) patent documents and status reports.
  3. WIPO Patent Scope and PCT applications.
  4. Industry patent landscaping reports for pharmaceutical innovations.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.